A Novel ex-vivo platform for personalized treatment in metastatic ovarian cancer.
A. Valdivia, R. A. Adefulajo, M. Thang, L. A. Cuaboy, C. John, B. E. Mann, A. B. Satterlee, V. Bae-Jump, S. D. Hingtgen
This study develops an ex-vivo platform using rat mesenteric membranes to assess treatment response in ovarian cancer, showing correlation with clinical outcomes.
bioRxiv · Mar 14, 2024 · PreprintCancer Biology